新型可代谢人用免疫佐剂。4. 65佐剂中高纯度流感病毒疫苗的研发。 - Suppr | 超能文献

New metabolizable immunologic adjuvant for human use. 4. Development of highly purified influenza virus vaccine in adjuvant 65.

作者信息

Woodhour A F, Metzgar D P, Lampson G P, Machlowitz R A, Tytell A A, Hilleman M R

出版信息

Proc Soc Exp Biol Med. 1966 Dec;123(3):778-82. doi: 10.3181/00379727-123-31601.

DOI:10.3181/00379727-123-31601

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

New metabolizable immunologic adjuvant for human use. 4. Development of highly purified influenza virus vaccine in adjuvant 65.新型可代谢人用免疫佐剂。4. 65佐剂中高纯度流感病毒疫苗的研发。

Proc Soc Exp Biol Med. 1966 Dec;123(3):778-82. doi: 10.3181/00379727-123-31601.

2

New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65.新型可代谢的人用免疫佐剂。5. 65号佐剂中高纯度流感病毒疫苗的评估。

N Engl J Med. 1967 Jan 12;276(2):78-84. doi: 10.1056/NEJM196701122760203.

3

NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE.新型可代谢的人用免疫佐剂。I. 研发与动物免疫反应。

Proc Soc Exp Biol Med. 1964 Jun;116:516-23. doi: 10.3181/00379727-116-29295.

4

NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS.新型可代谢的人用免疫佐剂。2. 短期动物毒性试验。

Proc Soc Exp Biol Med. 1964 Jun;116:523-30. doi: 10.3181/00379727-116-29296.

5

Influenza A(H5N1) Virus Subunit Vaccine Administered with CaPNP Adjuvant Induce High Virus Neutralization Antibody Titers in Mice.甲型 H5N1 流感病毒亚单位疫苗联合 CaPNP 佐剂在小鼠体内诱导高滴度病毒中和抗体。

AAPS PharmSciTech. 2019 Oct 7;20(8):315. doi: 10.1208/s12249-019-1530-9.

6

Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.五种佐剂对豚鼠流感病毒抗原抗体反应影响的比较。

Lab Anim Sci. 1995 Aug;45(4):420-6.

7

Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine.一种减毒活重组甲型H7N9流感种子株及相应MF59佐剂裂解疫苗的安全性和致病性的临床前评估。

Oncotarget. 2016 Dec 6;7(49):81012-81025. doi: 10.18632/oncotarget.12746.

8

The use of new polymethylmethacrylate adjuvants for split influenza vaccines.

Exp Cell Biol. 1976;44(1):12-9. doi: 10.1159/000162849.

9

Hyperpotentiation by synthetic double-stranded RNA of antibody responses to influenza virus vaccine in adjuvant 65.佐剂65中合成双链RNA对流感病毒疫苗抗体反应的超增强作用。

Proc Soc Exp Biol Med. 1969 Jul;131(3):809-17. doi: 10.3181/00379727-131-33983.

10

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.使用简单的亚微米油/水乳液佐剂MF59增强针对人用流感疫苗的体液免疫反应。

Vaccine. 1995 Nov;13(16):1557-62. doi: 10.1016/0264-410x(95)00089-j.

引用本文的文献

1

Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.一种新型可代谢脂质乳剂与灭活病毒疫苗的佐剂活性。

Infect Immun. 1980 Jun;28(3):937-43. doi: 10.1128/iai.28.3.937-943.1980.

2

The roles of early alert and of adjuvant in the control of Hong Kong influenza by vaccines.早期预警及辅助手段在通过疫苗控制香港流感方面的作用。

Bull World Health Organ. 1969;41(3):623-8.